PedAM
Pediatric Disease Annotations & Medicines
| Disease | thromboembolism |
| Phenotype | C0376358|prostate cancer |
| Sentences | 7 |
| PubMedID- 26497726 | Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation. |
| PubMedID- 20395174 | Risk of thromboembolic diseases in men with prostate cancer: results from the population-based pcbase sweden. |
| PubMedID- 26153520 | We identify a new procoagulant mechanism that contributes to thromboembolism in prostate cancer and allows for safe anticoagulation therapy development. |
| PubMedID- 22072494 | Androgen deprivation and thromboembolic events in men with prostate cancer. |
| PubMedID- 26149890 | Comorbidity and the risk of venous thromboembolism in prostate cancer. |
| PubMedID- 22859911 | Risk of venous thromboembolism in men with prostate cancer, with pooled incidence rates and 95% confidence intervals obtained from random effects meta-analysis. |
| PubMedID- 26138040 | Background: few observational studies have investigated the association between androgen deprivation therapy (adt) and venous thromboembolism (vte) in patients with prostate cancer (pca). |
Page: 1